Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +20.57% shed 0.18% to $333.01 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -2.53% rising 0.43% to 35,609.34 and the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -2.23% falling 0.05% to 15,121.68. This was the stock's second consecutive day of losses. Moderna Inc. closed $164.48 below its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -1.81% rose 0.89% to $108.41, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -1.41% rose 1.39% to $209.66, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.43% rose 0.76% to $60.63. Trading volume (4.7 M) remained 10.7 million below its 50-day average volume of 15.4 M.